Alnylam Pharmaceuticals | Fremdkapital



Loan Capital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 956K 2025-06
Amgen USD 53.76B 253M 2025-06
Arrowhead Research USD 200.33M 8.59M 2025-06
BioMarin Pharmaceutical USD 596.16M 512K 2025-06
Incyte USD 31.76M 883K 2025-06
Ionis Pharmaceuticals USD 625.49M 625.22M 2025-06
Moderna USD 32M 3M 2025-06
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 24.06B 1.13B 2025-06
PTC Therapeutics USD 2.13B 1.85B 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2025-06
Sanofi 14.72B 2.93B 2025-06
Sarepta Therapeutics USD 1.14B 1.17M 2025-06
Takeda JPY 4.13T 168.47B 2025-06
Tectonic Therapeutic USD 186K 201K 2025-06
Ultragenyx Pharmaceutical USD 782.75M 782.75M 2025-06
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Xencor USD 94.74M 7.1M 2025-06


Alnylam Pharmaceuticals Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.